Work

Comparative analysis of fatal serious adverse events associated with FDA-approved bispecific antibodies in hematologic malignancies

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-8065

Authors: Sneha Singh, Sangam Sangam, Thulasee Jose

Institutions: St. Barnabas Hospital, Stanford University

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417013445

Cites:

Cited by:

Related to: